Kestra Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $708K | Sell |
14,552
-1,888
| -11% | -$91.8K | ﹤0.01% | 1716 |
|
|
2025
Q1 | $559K | Buy |
16,440
+432
| +3% | +$14.7K | ﹤0.01% | 1753 |
|
|
2024
Q4 | $630K | Buy |
16,008
+3,843
| +32% | +$151K | ﹤0.01% | 1707 |
|
|
2024
Q3 | $572K | Sell |
12,165
-3,949
| -25% | -$186K | ﹤0.01% | 1683 |
|
|
2024
Q2 | $870K | Buy |
16,114
+407
| +3% | +$22K | ﹤0.01% | 1403 |
|
|
2024
Q1 | $1.07M | Buy |
15,707
+4,310
| +38% | +$294K | 0.01% | 1192 |
|
|
2023
Q4 | $713K | Buy |
11,397
+5,769
| +103% | +$361K | 0.01% | 1310 |
|
|
2023
Q3 | $255K | Sell |
5,628
-469
| -8% | -$21.3K | ﹤0.01% | 1777 |
|
|
2023
Q2 | $342K | Buy |
6,097
+92
| +2% | +$5.17K | ﹤0.01% | 1529 |
|
|
2023
Q1 | $272K | Sell |
6,005
-276
| -4% | -$12.5K | ﹤0.01% | 1634 |
|
|
2022
Q4 | $255K | Sell |
6,281
-457
| -7% | -$18.6K | ﹤0.01% | 1856 |
|
|
2022
Q3 | $440K | Sell |
6,738
-99
| -1% | -$6.47K | ﹤0.01% | 1390 |
|
|
2022
Q2 | $415K | Buy |
6,837
+1,427
| +26% | +$86.6K | ﹤0.01% | 1430 |
|
|
2022
Q1 | $340K | Buy |
5,410
+1,102
| +26% | +$69.3K | ﹤0.01% | 1520 |
|
|
2021
Q4 | $326K | Sell |
4,308
-8,164
| -65% | -$618K | ﹤0.01% | 1561 |
|
|
2021
Q3 | $1.4M | Buy |
12,472
+272
| +2% | +$30.4K | 0.01% | 847 |
|
|
2021
Q2 | $1.98M | Buy |
12,200
+6,219
| +104% | +$1.01M | 0.02% | 659 |
|
|
2021
Q1 | $729K | Sell |
5,981
-4,756
| -44% | -$580K | 0.01% | 1008 |
|
|
2020
Q4 | $1.74M | Buy |
+10,737
| New | +$1.74M | 0.02% | 641 |
|